70 studies found for:    Narcolepsy
Show Display Options
Rank Status Study
21 Completed
Has Results
Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions: Excessive Daytime Sleepiness;   Narcolepsy;   Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)
Intervention: Drug: Armodafinil
22 Completed
Has Results
Clarithromycin for the Treatment of Hypersomnia
Conditions: Hypersomnia;   Idiopathic Hypersomnia;   Narcolepsy
Interventions: Drug: Clarithromycin followed by placebo;   Drug: Placebo then Clarithromycin
23 Recruiting Narcolepsy - New Potential Treatment
Condition: Narcolepsy
Interventions: Device: Kinetic Oscillation Stimulation Device;   Device: Kinetic Oscillation Stimulation Device in placebo mode
24 Completed Provigil (Modafinil) Study by Taiwan Biotech Co.
Conditions: Narcolepsy;   Cataplexy;   Sleep Disorders;   Hypersomnolence;   Excessive Sleepiness
Intervention: Drug: Modafinil
25 Completed Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy
Conditions: Narcolepsy;   Cataplexy;   Excessive Daytime Sleepiness
Interventions: Drug: BF2.649;   Drug: BF2.649 add on Modafinil
26 Completed Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness
Condition: Narcolepsy
Intervention: Drug: Modafinil
27 Completed
Has Results
Flumazenil for the Treatment of Primary Hypersomnia
Conditions: Hypersomnia;   Primary Hypersomnia;   Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy
Intervention: Drug: Flumazenil
28 Unknown  Effect of Intranasal Administration of Orexine A on IL-6-System, Sleep-Wake-Regulation and Neurocognition
Condition: Narcolepsy
Intervention: Drug: Orexine A
29 Recruiting Neurophysiologic Correlates of Hypersomnia
Conditions: Major Depressive Disorder;   Primary Hypersomnia;   Bipolar Disorder;   Narcolepsy;   Primary Insomnia
Intervention: Other: Acoustical slow wave induction
30 Completed Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Sodium Oxybate (Xyrem)
31 Completed Sleep Disorders of Patients With Diseases of the Nervous System
Conditions: Hypersomnia;   Narcolepsy;   Nervous System Disease;   Sleep Disorder
Intervention:
32 Enrolling by invitation Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
Condition: Narcolepsy
Intervention:
33 Recruiting Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)
Conditions: Narcolepsy With Cataplexy;   Excessive Daytime Sleepiness
Interventions: Drug: Pitolisant;   Drug: Placebo
34 Recruiting Amylase and Hypersomnia
Condition: Hypersomnia in Children
Intervention: Procedure: saliva collection
35 Completed Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies
Conditions: Narcolepsy;   Hypersomnia
Interventions: Drug: Modafinil;   Drug: Placebo
36 Recruiting The Nuvigil and Provigil Pregnancy Registry
Conditions: Narcolepsy;   Obstructive Sleep Apnea;   Shift Work Sleep Disorder
Intervention: Drug: Modafinil/armodafinil
37 Recruiting Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)
Condition: Narcolepsy
Intervention: Drug: BF2.649
38 Recruiting Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study
Conditions: Obstructive Sleep Apnea of Adult;   Insomnia;   Circadian Rhythm Sleep Disorder, Unspecified Type;   Restless Legs Syndrome;   Narcolepsy and Hypersomnia
Interventions: Other: CONV care for the diagnosis and treatment of sleep disorders;   Other: PCCM for the diagnosis and treatment of sleep disorders
39 Completed Single-dose Safety Study of APD916 in Healthy Volunteers
Condition: Narcolepsy With or Without Cataplexy
Intervention: Drug: APD916
40 Recruiting A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
Condition: Narcolepsy, Excessive Daytime Sleepiness
Interventions: Drug: Placebo;   Drug: Sodium Oxybate;   Drug: JZP-386

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years